Drug-labels.com

Apo-Cefprozil (Apotex, 250 mg, 500 mg): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Dormant
Strength:
250 mg, 500 mg
ATC code:

Patient Medication Information: uses, side effects, how to take - Apo-Cefprozil (Apotex, 250 mg, 500 mg)

ABOUT THIS MEDICATION

APO-CEFPROZIL is the generic brand name for a drug called cefprozil.

What the medication is used for:

The most common uses of APO-CEFPROZIL are:

  • respiratory infections
  • urinary tract infections
  • skin infections
  • acute sinusitis

Antibacterial drugs like APO-CEFPROZIL treat only bacterial infections. They do not treat viral infections such as the common cold. Although you may feel better early in treatment, APO-CEFPROZIL should be used exactly as directed. Misuse or overuse of APO-CEFPROZIL could lead to the growth of bacteria that will not be killed by APO-CEFPROZIL (resistance). This means that APO-CEFPROZIL may not work for you in the future. Do not share your medicine.

For other possible uses, please speak to your doctor or pharmacist.

What it does:

APO-CEFPROZIL is an antibiotic.

When it should not be used:

Do not use if allergic to cefprozil or any of the nonmedicinal ingredients present in Apo-Cefprozil (See “What the important non-medicinal ingredients are” section below).

What the medicinal ingredient is:

APO-CEFPROZIL tablets contain the active ingredient called cefprozil.

What the important nonmedicinal ingredients are:

APO-CEFPROZIL tablets contain the following nonmedicinal ingredients: methylcellulose, microcrystalline cellulose, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, hydroxypropyl cellulose, hydroxypropyl methylcellulose, polyethylene glycol, titanium dioxide and sunset yellow aluminum lake (500 mg).

What dosage forms it comes in:

Tablets, 250 mg and 500 mg.

WARNINGS AND PRECAUTIONS

Before starting APO-CEFPROZIL and to get the best possible treatment, be sure to tell your doctor if you:

  • Are allergic to penicillins, cephalopsporins, cefprozil or any other drugs.
  • Do not use if you are pregnant, plan to become pregnant or are breastfeeding.

  • Do not use for children below the age of 6 months.

  • Caution is required when cefprozil is used for the chronically ill or institutionalized elderly.

INTERACTIONS WITH THIS MEDICATION

Drugs that may interact with Apo-Cefprozil include aminoglycoside antibiotics and probenecid.

Before you use APO-CEFPROZIL talk to your doctor or pharmacist.

PROPER USE OF THIS MEDICATION

Adults (13 years and older)

Usual dose:

Respiratory and Urinary Tract Infections: 500 mg once daily.

Skin Infections: 250 mg every 12 hours or 500 mg once daily.

Acute Sinusitis: 250 mg or 500 mg, every 12 hours.

Overdose:

Call your doctor or pharmacist right away in case of an overdose.

Missed Dose:

Call your doctor or pharmacist right away in case of a missed dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The most common side effects are diarrhea, nausea, vomiting and abdominal pain.

This is not a complete list of side effects. For any unexpected effects while taking APO-CEFPROZIL, contact your doctor or pharmacist.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

Severe Cutaneous Adverse Reactions (SCAR) (severe skin reactions that may also affect other organs):

  • Skin peeling, scaling, or blistering (with or without pus) which may also affect your eyes, mouth, nose or genitals, itching, severe rash, bumps under the skin, skin pain, skin color changes (redness, yellowing, purplish)
  • Swelling and redness of eyes or face
  • Flu-like feeling, fever, chills, body aches, swollen glands,
✓
  • cough
  • Shortness of breath, chest pain or discomfort

HOW TO STORE IT

Remember to keep APO-CEFPROZIL well out of reach of children. APO-CEFPROZIL should be stored at room temperature (15 oC to 30oC).

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about APO-CEFPROZIL:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this patient medication information by visiting the Health Canada website ( https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website http://www.apotex.ca/products, or by calling 1-800-667-4708.

Date of Revision: June 3, 2020

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02292998

Revision date stated in the text: June 3, 2020

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Apo-Cefprozil (Apotex, 250 mg, 500 mg)

Rx or OTC
Prescription (Rx)?
DIN 02292998, 02293005
Schedule(s) PRESCRIPTION
Active ingredient(s) Cefprozil (cefprozil monohydrate)
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01D Other beta-lactam antibacterials
        1. J01DC Second-generation cephalosporins
          1. J01DC10 Cefprozil
Company APOTEX INC
Current status Dormant
Strengths and forms
DIN Strength Dosage form(s) Current status
02292998 250 MG Tablet Dormant January 31, 2020
02293005 500 MG Tablet Dormant September 20, 2019

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.